🇺🇸 FDA
Patent

US 10232030

Vaccines for human papilloma virus and methods for using the same

granted A61KA61K2039/53A61K2039/54

Quick answer

US patent 10232030 (Vaccines for human papilloma virus and methods for using the same) held by Inovio Pharmaceuticals, Inc. expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/53, A61K2039/54, A61K2039/70, A61K39/12